导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 0.41% | 539/1050 |
| 近一周 | -1.34% | 183/1104 |
| 近一月 | 1.15% | 53/1102 |
| 近一季 | -0.18% | 262/1092 |
| 近半年 | -5.88% | 646/1070 |
| 近一年 | -2.78% | 631/1018 |
| 近两年 | 21.59% | 761/926 |
| 近三年 | 9.85% | 594/834 |
| 成立以来 | 43.59% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
4.25% 184/1070 |
-14.11% 1001/1101 |
- - |
- - |
| 2025 | 5.96% 868/1065 |
-0.60% 836/1014 |
8.07% 156/1038 |
0.04% 1005/1050 |
-1.41% 524/1065 |
| 2024 | 13.69% 204/1011 |
9.19% 35/960 |
6.50% 67/983 |
-1.65% 967/991 |
-0.59% 353/1011 |
| 2023 | -5.97% 222/952 |
0.98% 578/880 |
3.17% 66/895 |
-1.67% 144/915 |
-8.21% 773/952 |
| 2022 | -21.55% 393/867 |
-16.56% 336/773 |
-3.69% 748/806 |
-7.65% 127/845 |
5.69% 174/867 |
| 2021 | 1.16% 342/740 |
1.21% 104/580 |
6.46% 438/659 |
-9.99% 505/704 |
4.31% 252/740 |
| 2020 | 33.68% 334/554 |
-13.03% 397/419 |
13.13% 376/466 |
22.40% 36/517 |
11.01% 334/554 |
| 2019 | 27.79% 300/410 |
18.70% 944/1146 |
1.42% 209/1228 |
0.58% 321/390 |
5.54% 329/410 |
| 2018 | -19.37% 65/349 |
- - |
-0.09% 83/990 |
-2.80% 360/1000 |
-14.65% 861/1080 |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8316 | 54.00% |
| 招商前沿医疗保健股票C | 0.7978 | 53.69% |
| 招商医药健康产业股票 | 2.5730 | 48.73% |
| 嘉实医疗保健股票 | 2.5780 | 39.05% |
| 广发医药精选股票A | 1.3132 | 38.48% |
| 广发医药精选股票C | 1.2923 | 38.32% |
| 前海开源公共卫生股票A | 0.4690 | 37.42% |
| 前海开源公共卫生股票C | 0.4590 | 37.30% |
| 交银医药创新股票C | 3.0594 | 35.86% |
| 交银医药创新股票A | 2.8810 | 32.85% |
| 平安股息精选沪港深C VS. 东吴新产业精选股票A(580008) |